Skip to main content
Fig. 2 | Clinical Epigenetics

Fig. 2

From: A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients

Fig. 2

Estimation of CpGs on HOXA9 and HOXA10 promoters as diagnostic and prognostic markers for breast cancer. a Differences in the methylation status of the CpGs between tumor and paired normal tissues (diagnostic value). b Association between survival and the CpG methylation status (prognostic value, black: high, gray: low). c Correlation between methylation level of the CpGs and expression level of the HOXA9, HOXA10, and HOXA11 genes

Back to article page